Cargando…
Epidemiological Status of Thyroid Eye Disease in Central Iran
PURPOSE: To focus on clinical manifestations and epidemiology of thyroid eye disease (TED) in Central Iran's population. METHODS: In this retrospective case study, we analyzed all patients with TED who were referred to our oculoplastic clinic from 2015 to 2019. The patients' epidemiologica...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9128421/ https://www.ncbi.nlm.nih.gov/pubmed/35620368 http://dx.doi.org/10.4103/joco.joco_223_21 |
_version_ | 1784712557424017408 |
---|---|
author | Eshraghi, Bahram Nikdel, Mojgan Abbasi, Maryam |
author_facet | Eshraghi, Bahram Nikdel, Mojgan Abbasi, Maryam |
author_sort | Eshraghi, Bahram |
collection | PubMed |
description | PURPOSE: To focus on clinical manifestations and epidemiology of thyroid eye disease (TED) in Central Iran's population. METHODS: In this retrospective case study, we analyzed all patients with TED who were referred to our oculoplastic clinic from 2015 to 2019. The patients' epidemiological characteristics and clinical presentation were compared between different thyroid disease groups and genders. RESULTS: Overall, 383 patients (155 male; 40.5% and 228 female; 59.5%) were included. The mean age was 39.55 years (standard deviation ± 13.45, range 10–72). Most patients (89%) were hyperthyroid with the highest duration of ocular involvement among all categories (25.6 months). The most common signs on ophthalmic examinations were proptosis (80.4%), followed by eyelid retraction (72.3.0%). TED was classified as mild in 24.5%, moderate to severe in 67.6%, and sight-threatening in 7.9%. Thirty patients (7.8%) had active TED. CONCLUSIONS: This series with a relatively more significant number of TED cases in Central Iran found similar epidemiological and clinical characteristics of TED compared to other studies from Iran. Most of our patients were hyperthyroid, with more females compared to males. Proptosis and eyelid retraction were the most common manifestations. Most TED patients were classified as moderate to severe. |
format | Online Article Text |
id | pubmed-9128421 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Wolters Kluwer - Medknow |
record_format | MEDLINE/PubMed |
spelling | pubmed-91284212022-05-25 Epidemiological Status of Thyroid Eye Disease in Central Iran Eshraghi, Bahram Nikdel, Mojgan Abbasi, Maryam J Curr Ophthalmol Original Article PURPOSE: To focus on clinical manifestations and epidemiology of thyroid eye disease (TED) in Central Iran's population. METHODS: In this retrospective case study, we analyzed all patients with TED who were referred to our oculoplastic clinic from 2015 to 2019. The patients' epidemiological characteristics and clinical presentation were compared between different thyroid disease groups and genders. RESULTS: Overall, 383 patients (155 male; 40.5% and 228 female; 59.5%) were included. The mean age was 39.55 years (standard deviation ± 13.45, range 10–72). Most patients (89%) were hyperthyroid with the highest duration of ocular involvement among all categories (25.6 months). The most common signs on ophthalmic examinations were proptosis (80.4%), followed by eyelid retraction (72.3.0%). TED was classified as mild in 24.5%, moderate to severe in 67.6%, and sight-threatening in 7.9%. Thirty patients (7.8%) had active TED. CONCLUSIONS: This series with a relatively more significant number of TED cases in Central Iran found similar epidemiological and clinical characteristics of TED compared to other studies from Iran. Most of our patients were hyperthyroid, with more females compared to males. Proptosis and eyelid retraction were the most common manifestations. Most TED patients were classified as moderate to severe. Wolters Kluwer - Medknow 2022-04-16 /pmc/articles/PMC9128421/ /pubmed/35620368 http://dx.doi.org/10.4103/joco.joco_223_21 Text en Copyright: © 2022 Journal of Current Ophthalmology https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
spellingShingle | Original Article Eshraghi, Bahram Nikdel, Mojgan Abbasi, Maryam Epidemiological Status of Thyroid Eye Disease in Central Iran |
title | Epidemiological Status of Thyroid Eye Disease in Central Iran |
title_full | Epidemiological Status of Thyroid Eye Disease in Central Iran |
title_fullStr | Epidemiological Status of Thyroid Eye Disease in Central Iran |
title_full_unstemmed | Epidemiological Status of Thyroid Eye Disease in Central Iran |
title_short | Epidemiological Status of Thyroid Eye Disease in Central Iran |
title_sort | epidemiological status of thyroid eye disease in central iran |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9128421/ https://www.ncbi.nlm.nih.gov/pubmed/35620368 http://dx.doi.org/10.4103/joco.joco_223_21 |
work_keys_str_mv | AT eshraghibahram epidemiologicalstatusofthyroideyediseaseincentraliran AT nikdelmojgan epidemiologicalstatusofthyroideyediseaseincentraliran AT abbasimaryam epidemiologicalstatusofthyroideyediseaseincentraliran |